LACTOSE (INDIA)
Back to Balance Sheet
|
LACTOSE (INDIA) Last 5 Year Total Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹133 Cr | ₹101 Cr | ₹101 Cr | ₹90 Cr | ₹88 Cr |
What is the latest Total Liabilities ratio of LACTOSE (INDIA) ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹133 Cr |
| Mar2024 | ₹101 Cr |
| Mar2023 | ₹101 Cr |
| Mar2022 | ₹90 Cr |
| Mar2021 | ₹88 Cr |
How is Total Liabilities of LACTOSE (INDIA) Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹133 Cr | 32.49 | |
| Mar2024 | ₹101 Cr | -0.54 | |
| Mar2023 | ₹101 Cr | 12.27 | |
| Mar2022 | ₹90 Cr | 2.13 | |
| Mar2021 | ₹88 Cr | - | |
Compare Total Liabilities of peers of LACTOSE (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LACTOSE (INDIA) | ₹131.8 Cr | 6.9% | 5.7% | 6.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹477,312.0 Cr | 3.1% | 7.2% | 18.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹213,879.0 Cr | 8.2% | 19.8% | 17.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹194,094.0 Cr | -1.8% | 4.9% | 37.2% | Stock Analytics | |
| CIPLA | ₹118,992.0 Cr | 3.9% | 0.6% | 0% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹95,787.4 Cr | -0.7% | -14.6% | -8.4% | Stock Analytics | |
LACTOSE (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LACTOSE (INDIA) | 6.9% |
5.7% |
6.4% |
| SENSEX | 2.7% |
1.5% |
-5.6% |
You may also like the below Video Courses